India-EU trade pact: ‘Roadmap for access to innovative drugs, but concerns remain on IP’
Public health and treatment activists are concerned on the IP front, and called for a release of the full text of the agreement for public scrutiny
Public health and treatment activists are concerned on the IP front, and called for a release of the full text of the agreement for public scrutiny
What's Your Reaction?
Economist Admin
Admin managing news updates, RSS feed curation, and PR content publishing. Focused on timely, accurate, and impactful information delivery.
